WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010047765) NANOSTRUCTURES FOR DRUG DELIVERY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/047765    International Application No.:    PCT/US2009/005687
Publication Date: 29.04.2010 International Filing Date: 20.10.2009
IPC:
A61K 9/16 (2006.01), A61K 33/24 (2006.01), A61P 13/08 (2006.01)
Applicants: MASSACHUSETTS INSTITUTE OF TECHNOLOGY [US/US]; 77 Massachusetts Avenue Cambridge, MA 02139 (US) (For All Designated States Except US).
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. [US/US]; 75 Francis Street Boston, MA 02115 (US) (For All Designated States Except US).
LIPPARD, Stephen, J. [US/US]; (US) (For US Only).
DHAR, Shanta [IN/US]; (US) (For US Only).
FAROKHZAD, Omid, C. [US/US]; (US) (For US Only).
KOLISHETTI, Nagesh [IN/US]; (US) (For US Only).
GU, Frank, X. [CA/CA]; (CA) (For US Only)
Inventors: LIPPARD, Stephen, J.; (US).
DHAR, Shanta; (US).
FAROKHZAD, Omid, C.; (US).
KOLISHETTI, Nagesh; (US).
GU, Frank, X.; (CA)
Agent: OYER, Timothy, J.; Wolf, Greenfield & Sacks, P.C. Federal Reserve Plaza 600 Atlantic Avenue Boston, MA 02210-2206 (US)
Priority Data:
61/106,792 20.10.2008 US
Title (EN) NANOSTRUCTURES FOR DRUG DELIVERY
(FR) NANOSTRUCTURES POUR L'ADMINISTRATION DE MÉDICAMENT
Abstract: front page image
(EN)The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects having cancer or at risk of developing cancer. Some embodiments of the invention may comprise a composition comprising a plurality of particles comprising a platinum(IV) therapeutically active precursor.
(FR)La présente invention concerne des compositions, des préparations, des formulations, des trousses, et des procédés utiles pour traiter des sujets ayant un cancer ou présentant un risque de développer un cancer. Certains modes de réalisation de l'invention peuvent comprendre une composition comprenant une pluralité de particules comprenant un précurseur thérapeutiquement actif de platine (IV).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)